PACS Group Inc. (PACS)
NYSE: PACSHealthcareMedical Care FacilitiesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
PACS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $6.84B
- P/E (TTM)
- 24.97
- Forward P/E
- 15.81
- EPS (TTM)
- $1.73
- Dividend yield
- None
- 52-week range
- 10.31 – 49.49
- Day range
- 42.43 – 43.68
- Volume / Avg
- 673.03K / 804.85K
- Beta
- —
- Shares outstanding
- 158.34M
52-week range
PACS stock today
PACS Group (PACS) closed at $43.19 on Oct 7, up 0.89% (+$0.38), versus the S&P 500's 0.22% decline. Shares are 12.7% below their 52-week high of $49.49, set on Aug 6, 2026 and 318.9% above the 52-week low of $10.31, near the top of the past year's range. PACS is up 12.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 224.7%.
At 25.0x trailing earnings, PACS Group trades above the peer-group median of 20.1x. Its forward P/E of 15.8x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About PACS Group
Company profilePACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- CEO
- Mr. Jason Murray
- Headquarters
- Salt Lake City, UT
- Employees
- 47,455
- IPO year
- 2024
- Website
- pacs.com
Financial highlights
Full financialsIn fiscal 2025, PACS Group generated $5.29 billion in revenue, up 29.3% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $191.5 million (+243.5% year over year), for a net margin of 3.6% versus a median of 3.6% in the prior 3 years. Gross margin was 21.9% (up from 19.4%) and operating margin 5.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | $5.29B | $4.09B | $3.11B | $2.42B |
| Growth | +29.32% | +31.44% | +28.47% | — |
| Net income | $191.54M | $55.76M | $112.87M | $150.50M |
| EPS (diluted) | $1.22 | $0.38 | $0.88 | $1.17 |
Analyst forecast
ForecastConsensus (6 analysts)
strong_buy
Avg. price target
$59.00+36.61%
- Strong buy 2
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Q2 2026)
- Aug 4, 2026
- EPS actual vs est.
- $0.47 vs —
PACS Group peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CHEChemed Corp | 501.45 | -1.65% | $6.55B | vs PACS |
| OPCHOption Care Health Inc. | 31.01 | +0.03% | $4.65B | vs PACS |
| ARDTArdent Health Inc. | 10.88 | +1.87% | $1.53B | vs PACS |
| NUTXNutex Health Inc. | 213.02 | -2.46% | $1.46B | vs PACS |
| AGLagilon health inc. | 85.70 | +2.76% | $1.44B | vs PACS |
| HCSGHealthcare Services Group Inc. | 20.79 | -1.61% | $1.43B | vs PACS |
| AMNAMN Healthcare Services Inc | 36.53 | -0.54% | $1.41B | vs PACS |
| PNTGThe Pennant Group Inc. | 39.62 | -0.84% | $1.38B | vs PACS |
Indexes, lists and sector
Appears in lists
PACS Group stock FAQ
What is PACS Group's stock price today?
PACS last traded at $43.19 as of Oct 7, 4:00 PM EDT, up 0.89% on the day. Prices are delayed at least 15 minutes.
What is PACS's P/E ratio?
PACS trades at a trailing P/E ratio of 24.97 and a forward P/E of 15.81, compared with a median of 20.1 for its closest peers.
Who is PACS Group's CEO?
Mr. Jason Murray is the chief executive officer of PACS Group Inc., which has about 47,455 employees.
What is the PACS 52-week high?
The 52-week high for PACS is $49.49 and the 52-week low is $10.31. The stock is currently 12.7% below its high.